nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—SLC29A1—Fluorouracil—colon cancer	0.752	0.919	CbGbCtD
Didanosine—SLC22A6—Methotrexate—colon cancer	0.0663	0.081	CbGbCtD
Didanosine—PNP—renal system—colon cancer	0.00758	0.137	CbGeAlD
Didanosine—PNP—lymphoid tissue—colon cancer	0.00629	0.114	CbGeAlD
Didanosine—PNP—digestive system—colon cancer	0.00622	0.112	CbGeAlD
Didanosine—Sickness—Irinotecan—colon cancer	0.00576	0.0456	CcSEcCtD
Didanosine—PNP—bone marrow—colon cancer	0.00573	0.103	CbGeAlD
Didanosine—PNP—liver—colon cancer	0.00463	0.0835	CbGeAlD
Didanosine—SLC29A2—vagina—colon cancer	0.00412	0.0744	CbGeAlD
Didanosine—Hepatic steatosis—Capecitabine—colon cancer	0.00355	0.0281	CcSEcCtD
Didanosine—SLC29A2—liver—colon cancer	0.00348	0.0628	CbGeAlD
Didanosine—SLC29A1—renal system—colon cancer	0.00282	0.0509	CbGeAlD
Didanosine—SLC29A2—lymph node—colon cancer	0.00267	0.0481	CbGeAlD
Didanosine—SLC29A1—lymphoid tissue—colon cancer	0.00234	0.0423	CbGeAlD
Didanosine—SLC29A1—digestive system—colon cancer	0.00231	0.0418	CbGeAlD
Didanosine—Hepatomegaly—Irinotecan—colon cancer	0.00226	0.0179	CcSEcCtD
Didanosine—Retinal disorder—Methotrexate—colon cancer	0.00223	0.0177	CcSEcCtD
Didanosine—Neuritis—Vincristine—colon cancer	0.0022	0.0174	CcSEcCtD
Didanosine—SLC29A1—bone marrow—colon cancer	0.00213	0.0385	CbGeAlD
Didanosine—SLC29A1—vagina—colon cancer	0.00204	0.0369	CbGeAlD
Didanosine—Numbness—Vincristine—colon cancer	0.00198	0.0157	CcSEcCtD
Didanosine—Tingling sensation—Fluorouracil—colon cancer	0.00191	0.0151	CcSEcCtD
Didanosine—Sensory loss—Vincristine—colon cancer	0.0019	0.015	CcSEcCtD
Didanosine—Leukoderma—Methotrexate—colon cancer	0.00188	0.0148	CcSEcCtD
Didanosine—Numbness—Fluorouracil—colon cancer	0.00185	0.0146	CcSEcCtD
Didanosine—Drug interaction—Vincristine—colon cancer	0.00177	0.014	CcSEcCtD
Didanosine—Hyperuricaemia—Vincristine—colon cancer	0.00177	0.014	CcSEcCtD
Didanosine—Sensory loss—Fluorouracil—colon cancer	0.00177	0.014	CcSEcCtD
Didanosine—SLC29A1—liver—colon cancer	0.00172	0.0311	CbGeAlD
Didanosine—Nephropathy—Methotrexate—colon cancer	0.00167	0.0133	CcSEcCtD
Didanosine—Blood uric acid increased—Vincristine—colon cancer	0.00167	0.0132	CcSEcCtD
Didanosine—Inflammation—Fluorouracil—colon cancer	0.00158	0.0125	CcSEcCtD
Didanosine—Neuropathy—Vincristine—colon cancer	0.00154	0.0122	CcSEcCtD
Didanosine—Hepatomegaly—Capecitabine—colon cancer	0.00151	0.012	CcSEcCtD
Didanosine—Hepatotoxicity—Capecitabine—colon cancer	0.00139	0.011	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.00134	0.0106	CcSEcCtD
Didanosine—Tingling sensation—Capecitabine—colon cancer	0.00133	0.0105	CcSEcCtD
Didanosine—Hepatic failure—Vincristine—colon cancer	0.00133	0.0105	CcSEcCtD
Didanosine—SLC29A1—lymph node—colon cancer	0.00132	0.0239	CbGeAlD
Didanosine—Renal failure acute—Irinotecan—colon cancer	0.00126	0.00996	CcSEcCtD
Didanosine—Renal impairment—Irinotecan—colon cancer	0.00122	0.00966	CcSEcCtD
Didanosine—Anaphylactoid reaction—Irinotecan—colon cancer	0.0012	0.0095	CcSEcCtD
Didanosine—Inflammation—Capecitabine—colon cancer	0.0011	0.00874	CcSEcCtD
Didanosine—Hepatotoxicity—Methotrexate—colon cancer	0.00103	0.00817	CcSEcCtD
Didanosine—Neuropathy—Capecitabine—colon cancer	0.00101	0.00796	CcSEcCtD
Didanosine—Dry eye—Capecitabine—colon cancer	0.000989	0.00783	CcSEcCtD
Didanosine—Pancreatitis—Irinotecan—colon cancer	0.000984	0.00779	CcSEcCtD
Didanosine—Neuropathy peripheral—Vincristine—colon cancer	0.000901	0.00713	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.000894	0.00707	CcSEcCtD
Didanosine—Diabetes mellitus—Capecitabine—colon cancer	0.000894	0.00707	CcSEcCtD
Didanosine—Hepatic function abnormal—Capecitabine—colon cancer	0.00089	0.00704	CcSEcCtD
Didanosine—Hepatic failure—Capecitabine—colon cancer	0.000865	0.00685	CcSEcCtD
Didanosine—Hyperuricaemia—Methotrexate—colon cancer	0.000859	0.0068	CcSEcCtD
Didanosine—Renal failure acute—Capecitabine—colon cancer	0.000842	0.00666	CcSEcCtD
Didanosine—Neuropathy peripheral—Fluorouracil—colon cancer	0.00084	0.00665	CcSEcCtD
Didanosine—Inflammation—Methotrexate—colon cancer	0.000822	0.0065	CcSEcCtD
Didanosine—Hypoaesthesia—Vincristine—colon cancer	0.000821	0.0065	CcSEcCtD
Didanosine—Renal impairment—Capecitabine—colon cancer	0.000817	0.00646	CcSEcCtD
Didanosine—Blood uric acid increased—Methotrexate—colon cancer	0.000812	0.00642	CcSEcCtD
Didanosine—Agranulocytosis—Fluorouracil—colon cancer	0.0008	0.00633	CcSEcCtD
Didanosine—Hypoaesthesia—Fluorouracil—colon cancer	0.000766	0.00606	CcSEcCtD
Didanosine—Alopecia—Vincristine—colon cancer	0.000729	0.00577	CcSEcCtD
Didanosine—Chills—Irinotecan—colon cancer	0.000721	0.00571	CcSEcCtD
Didanosine—Alopecia—Irinotecan—colon cancer	0.00071	0.00562	CcSEcCtD
Didanosine—Abdominal pain upper—Capecitabine—colon cancer	0.00071	0.00562	CcSEcCtD
Didanosine—Flatulence—Irinotecan—colon cancer	0.000689	0.00545	CcSEcCtD
Didanosine—Alopecia—Fluorouracil—colon cancer	0.00068	0.00538	CcSEcCtD
Didanosine—Diabetes mellitus—Methotrexate—colon cancer	0.000665	0.00527	CcSEcCtD
Didanosine—Anaemia—Vincristine—colon cancer	0.000664	0.00525	CcSEcCtD
Didanosine—Anaemia—Irinotecan—colon cancer	0.000647	0.00512	CcSEcCtD
Didanosine—Hepatic failure—Methotrexate—colon cancer	0.000644	0.0051	CcSEcCtD
Didanosine—Leukopenia—Vincristine—colon cancer	0.000643	0.00509	CcSEcCtD
Didanosine—Malaise—Irinotecan—colon cancer	0.000631	0.00499	CcSEcCtD
Didanosine—Renal failure acute—Methotrexate—colon cancer	0.000627	0.00496	CcSEcCtD
Didanosine—Leukopenia—Irinotecan—colon cancer	0.000626	0.00495	CcSEcCtD
Didanosine—Anaemia—Fluorouracil—colon cancer	0.000619	0.0049	CcSEcCtD
Didanosine—Myalgia—Vincristine—colon cancer	0.000611	0.00484	CcSEcCtD
Didanosine—Hyperglycaemia—Capecitabine—colon cancer	0.000606	0.0048	CcSEcCtD
Didanosine—Leukopenia—Fluorouracil—colon cancer	0.0006	0.00475	CcSEcCtD
Didanosine—Anaphylactoid reaction—Methotrexate—colon cancer	0.000598	0.00473	CcSEcCtD
Didanosine—Discomfort—Irinotecan—colon cancer	0.000588	0.00466	CcSEcCtD
Didanosine—Neuropathy peripheral—Capecitabine—colon cancer	0.000587	0.00465	CcSEcCtD
Didanosine—Anaphylactic shock—Vincristine—colon cancer	0.000586	0.00464	CcSEcCtD
Didanosine—Infection—Vincristine—colon cancer	0.000582	0.00461	CcSEcCtD
Didanosine—Thrombocytopenia—Vincristine—colon cancer	0.000574	0.00454	CcSEcCtD
Didanosine—Anaphylactic shock—Irinotecan—colon cancer	0.000571	0.00452	CcSEcCtD
Didanosine—Myalgia—Fluorouracil—colon cancer	0.00057	0.00451	CcSEcCtD
Didanosine—Infection—Irinotecan—colon cancer	0.000567	0.00449	CcSEcCtD
Didanosine—Hepatobiliary disease—Capecitabine—colon cancer	0.000567	0.00448	CcSEcCtD
Didanosine—Discomfort—Fluorouracil—colon cancer	0.000564	0.00446	CcSEcCtD
Didanosine—Agranulocytosis—Capecitabine—colon cancer	0.000559	0.00442	CcSEcCtD
Didanosine—Thrombocytopenia—Irinotecan—colon cancer	0.000559	0.00442	CcSEcCtD
Didanosine—Anorexia—Vincristine—colon cancer	0.000559	0.00442	CcSEcCtD
Didanosine—Anaphylactic shock—Fluorouracil—colon cancer	0.000547	0.00433	CcSEcCtD
Didanosine—Anorexia—Irinotecan—colon cancer	0.000544	0.00431	CcSEcCtD
Didanosine—Infection—Fluorouracil—colon cancer	0.000543	0.0043	CcSEcCtD
Didanosine—Hepatitis—Capecitabine—colon cancer	0.000538	0.00426	CcSEcCtD
Didanosine—Thrombocytopenia—Fluorouracil—colon cancer	0.000535	0.00424	CcSEcCtD
Didanosine—Hypoaesthesia—Capecitabine—colon cancer	0.000535	0.00423	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000534	0.00423	CcSEcCtD
Didanosine—Paraesthesia—Vincristine—colon cancer	0.000526	0.00417	CcSEcCtD
Didanosine—Anorexia—Fluorouracil—colon cancer	0.000521	0.00412	CcSEcCtD
Didanosine—Paraesthesia—Irinotecan—colon cancer	0.000513	0.00406	CcSEcCtD
Didanosine—Decreased appetite—Vincristine—colon cancer	0.00051	0.00403	CcSEcCtD
Didanosine—Dyspepsia—Irinotecan—colon cancer	0.000503	0.00398	CcSEcCtD
Didanosine—Pain—Vincristine—colon cancer	0.000501	0.00397	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000498	0.00394	CcSEcCtD
Didanosine—Decreased appetite—Irinotecan—colon cancer	0.000496	0.00393	CcSEcCtD
Didanosine—Paraesthesia—Fluorouracil—colon cancer	0.000491	0.00389	CcSEcCtD
Didanosine—Pancreatitis—Methotrexate—colon cancer	0.00049	0.00388	CcSEcCtD
Didanosine—Pain—Irinotecan—colon cancer	0.000488	0.00386	CcSEcCtD
Didanosine—Chills—Capecitabine—colon cancer	0.000483	0.00382	CcSEcCtD
Didanosine—Dyspepsia—Fluorouracil—colon cancer	0.000481	0.00381	CcSEcCtD
Didanosine—Gastrointestinal pain—Vincristine—colon cancer	0.000479	0.00379	CcSEcCtD
Didanosine—Decreased appetite—Fluorouracil—colon cancer	0.000475	0.00376	CcSEcCtD
Didanosine—Alopecia—Capecitabine—colon cancer	0.000475	0.00376	CcSEcCtD
Didanosine—Pain—Fluorouracil—colon cancer	0.000468	0.0037	CcSEcCtD
Didanosine—Gastrointestinal pain—Irinotecan—colon cancer	0.000467	0.00369	CcSEcCtD
Didanosine—Body temperature increased—Vincristine—colon cancer	0.000463	0.00367	CcSEcCtD
Didanosine—Abdominal pain—Vincristine—colon cancer	0.000463	0.00367	CcSEcCtD
Didanosine—Flatulence—Capecitabine—colon cancer	0.000461	0.00365	CcSEcCtD
Didanosine—Abdominal pain—Irinotecan—colon cancer	0.000451	0.00357	CcSEcCtD
Didanosine—Body temperature increased—Irinotecan—colon cancer	0.000451	0.00357	CcSEcCtD
Didanosine—Anaemia—Capecitabine—colon cancer	0.000433	0.00342	CcSEcCtD
Didanosine—Body temperature increased—Fluorouracil—colon cancer	0.000432	0.00342	CcSEcCtD
Didanosine—Hypersensitivity—Vincristine—colon cancer	0.000432	0.00342	CcSEcCtD
Didanosine—Malaise—Capecitabine—colon cancer	0.000422	0.00334	CcSEcCtD
Didanosine—Hepatobiliary disease—Methotrexate—colon cancer	0.000422	0.00334	CcSEcCtD
Didanosine—Hypersensitivity—Irinotecan—colon cancer	0.000421	0.00333	CcSEcCtD
Didanosine—Asthenia—Vincristine—colon cancer	0.000421	0.00333	CcSEcCtD
Didanosine—Leukopenia—Capecitabine—colon cancer	0.000419	0.00332	CcSEcCtD
Didanosine—Agranulocytosis—Methotrexate—colon cancer	0.000416	0.00329	CcSEcCtD
Didanosine—Asthenia—Irinotecan—colon cancer	0.00041	0.00324	CcSEcCtD
Didanosine—Hypersensitivity—Fluorouracil—colon cancer	0.000403	0.00319	CcSEcCtD
Didanosine—Diarrhoea—Vincristine—colon cancer	0.000401	0.00317	CcSEcCtD
Didanosine—Hepatitis—Methotrexate—colon cancer	0.0004	0.00317	CcSEcCtD
Didanosine—Myalgia—Capecitabine—colon cancer	0.000399	0.00315	CcSEcCtD
Didanosine—Arthralgia—Capecitabine—colon cancer	0.000399	0.00315	CcSEcCtD
Didanosine—Discomfort—Capecitabine—colon cancer	0.000394	0.00312	CcSEcCtD
Didanosine—Diarrhoea—Irinotecan—colon cancer	0.000391	0.00309	CcSEcCtD
Didanosine—Dry mouth—Capecitabine—colon cancer	0.00039	0.00308	CcSEcCtD
Didanosine—Pruritus—Fluorouracil—colon cancer	0.000387	0.00306	CcSEcCtD
Didanosine—Infection—Capecitabine—colon cancer	0.00038	0.003	CcSEcCtD
Didanosine—Diarrhoea—Fluorouracil—colon cancer	0.000374	0.00296	CcSEcCtD
Didanosine—Thrombocytopenia—Capecitabine—colon cancer	0.000374	0.00296	CcSEcCtD
Didanosine—Vomiting—Vincristine—colon cancer	0.000373	0.00295	CcSEcCtD
Didanosine—Rash—Vincristine—colon cancer	0.00037	0.00292	CcSEcCtD
Didanosine—Dermatitis—Vincristine—colon cancer	0.000369	0.00292	CcSEcCtD
Didanosine—Headache—Vincristine—colon cancer	0.000367	0.00291	CcSEcCtD
Didanosine—Anorexia—Capecitabine—colon cancer	0.000364	0.00288	CcSEcCtD
Didanosine—Vomiting—Irinotecan—colon cancer	0.000363	0.00287	CcSEcCtD
Didanosine—Rash—Irinotecan—colon cancer	0.00036	0.00285	CcSEcCtD
Didanosine—Dermatitis—Irinotecan—colon cancer	0.00036	0.00285	CcSEcCtD
Didanosine—Chills—Methotrexate—colon cancer	0.000359	0.00284	CcSEcCtD
Didanosine—Headache—Irinotecan—colon cancer	0.000358	0.00283	CcSEcCtD
Didanosine—Alopecia—Methotrexate—colon cancer	0.000354	0.0028	CcSEcCtD
Didanosine—Nausea—Vincristine—colon cancer	0.000348	0.00276	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000348	0.00275	CcSEcCtD
Didanosine—Vomiting—Fluorouracil—colon cancer	0.000348	0.00275	CcSEcCtD
Didanosine—Rash—Fluorouracil—colon cancer	0.000345	0.00273	CcSEcCtD
Didanosine—Dermatitis—Fluorouracil—colon cancer	0.000344	0.00273	CcSEcCtD
Didanosine—Paraesthesia—Capecitabine—colon cancer	0.000343	0.00272	CcSEcCtD
Didanosine—Headache—Fluorouracil—colon cancer	0.000343	0.00271	CcSEcCtD
Didanosine—Nausea—Irinotecan—colon cancer	0.000339	0.00268	CcSEcCtD
Didanosine—Dyspepsia—Capecitabine—colon cancer	0.000336	0.00266	CcSEcCtD
Didanosine—Decreased appetite—Capecitabine—colon cancer	0.000332	0.00263	CcSEcCtD
Didanosine—Pain—Capecitabine—colon cancer	0.000327	0.00259	CcSEcCtD
Didanosine—Nausea—Fluorouracil—colon cancer	0.000325	0.00257	CcSEcCtD
Didanosine—Anaemia—Methotrexate—colon cancer	0.000322	0.00255	CcSEcCtD
Didanosine—Malaise—Methotrexate—colon cancer	0.000314	0.00249	CcSEcCtD
Didanosine—Gastrointestinal pain—Capecitabine—colon cancer	0.000312	0.00247	CcSEcCtD
Didanosine—Leukopenia—Methotrexate—colon cancer	0.000312	0.00247	CcSEcCtD
Didanosine—Abdominal pain—Capecitabine—colon cancer	0.000302	0.00239	CcSEcCtD
Didanosine—Body temperature increased—Capecitabine—colon cancer	0.000302	0.00239	CcSEcCtD
Didanosine—Myalgia—Methotrexate—colon cancer	0.000297	0.00235	CcSEcCtD
Didanosine—Arthralgia—Methotrexate—colon cancer	0.000297	0.00235	CcSEcCtD
Didanosine—Discomfort—Methotrexate—colon cancer	0.000293	0.00232	CcSEcCtD
Didanosine—Anaphylactic shock—Methotrexate—colon cancer	0.000284	0.00225	CcSEcCtD
Didanosine—Infection—Methotrexate—colon cancer	0.000283	0.00224	CcSEcCtD
Didanosine—Hypersensitivity—Capecitabine—colon cancer	0.000281	0.00223	CcSEcCtD
Didanosine—Thrombocytopenia—Methotrexate—colon cancer	0.000278	0.0022	CcSEcCtD
Didanosine—Asthenia—Capecitabine—colon cancer	0.000274	0.00217	CcSEcCtD
Didanosine—Anorexia—Methotrexate—colon cancer	0.000271	0.00215	CcSEcCtD
Didanosine—Pruritus—Capecitabine—colon cancer	0.00027	0.00214	CcSEcCtD
Didanosine—Diarrhoea—Capecitabine—colon cancer	0.000261	0.00207	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000259	0.00205	CcSEcCtD
Didanosine—Paraesthesia—Methotrexate—colon cancer	0.000255	0.00202	CcSEcCtD
Didanosine—Dyspepsia—Methotrexate—colon cancer	0.00025	0.00198	CcSEcCtD
Didanosine—Decreased appetite—Methotrexate—colon cancer	0.000247	0.00196	CcSEcCtD
Didanosine—Pain—Methotrexate—colon cancer	0.000243	0.00192	CcSEcCtD
Didanosine—Vomiting—Capecitabine—colon cancer	0.000243	0.00192	CcSEcCtD
Didanosine—Rash—Capecitabine—colon cancer	0.000241	0.00191	CcSEcCtD
Didanosine—Dermatitis—Capecitabine—colon cancer	0.000241	0.0019	CcSEcCtD
Didanosine—Headache—Capecitabine—colon cancer	0.000239	0.00189	CcSEcCtD
Didanosine—Gastrointestinal pain—Methotrexate—colon cancer	0.000233	0.00184	CcSEcCtD
Didanosine—Nausea—Capecitabine—colon cancer	0.000227	0.0018	CcSEcCtD
Didanosine—Body temperature increased—Methotrexate—colon cancer	0.000225	0.00178	CcSEcCtD
Didanosine—Abdominal pain—Methotrexate—colon cancer	0.000225	0.00178	CcSEcCtD
Didanosine—Hypersensitivity—Methotrexate—colon cancer	0.00021	0.00166	CcSEcCtD
Didanosine—Asthenia—Methotrexate—colon cancer	0.000204	0.00161	CcSEcCtD
Didanosine—Pruritus—Methotrexate—colon cancer	0.000201	0.00159	CcSEcCtD
Didanosine—Diarrhoea—Methotrexate—colon cancer	0.000195	0.00154	CcSEcCtD
Didanosine—Vomiting—Methotrexate—colon cancer	0.000181	0.00143	CcSEcCtD
Didanosine—Rash—Methotrexate—colon cancer	0.000179	0.00142	CcSEcCtD
Didanosine—Dermatitis—Methotrexate—colon cancer	0.000179	0.00142	CcSEcCtD
Didanosine—Headache—Methotrexate—colon cancer	0.000178	0.00141	CcSEcCtD
Didanosine—Nausea—Methotrexate—colon cancer	0.000169	0.00134	CcSEcCtD
